Differential co-expression analysis of rheumatoid arthritis with microarray data

Molecular Medicine Reports

Volumn 10, Issue 5, 2014, Pages 2421-2426

  Wang, Kunpeng ^a   Zhao, Liqiang ^b   Liu, Xuefeng ^a   Hao, Zhenyong ^b   Zhou, Yong ^a   Yang, Chuandong ^a   Li, Hongqiang ^b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Harbin Fifth Hospital   (China)

Author keywords

Differential co expression; Differentially co expressed links; Differentially expressed genes; Rheumatoid arthritis

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 4; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR CEBPE; TRANSCRIPTION FACTOR ETS 2; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR PBX1; TRANSCRIPTION FACTOR PLAU; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; TRANSCRIPTOME;

ARTICLE; CLINICAL ARTICLE; GENE EXPRESSION PROFILING; HUMAN; MICROARRAY ANALYSIS; OSTEOARTHRITIS; PATHOGENESIS; RHEUMATOID ARTHRITIS; STUDENT T TEST; TRANSCRIPTION REGULATION; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETIC TRANSCRIPTION; METABOLISM; PHYSIOLOGY;

ARTHRITIS, RHEUMATOID; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSCRIPTOME;

EID: 84907227463     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2491     Document Type: Article

References (41)

1. Raza K: The Michael Mason prize: early rheumatoid arthritis - the window narrows. Rheumatology (Oxford) 49: 406-410, 2010.
2. Nell V, Machold K, Eberl G, Stamm T, Uffmann M and Smolen J: Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology (Oxford) 43: 906-914, 2004.
3. Bigelow RL, Jen EY, Delehedde M, Chari NS and McDonnell TJ: Sonic hedgehog induces epidermal growth factor dependent matrix infiltration in HaCaT keratinocytes. J Invest Dermatol 124: 457-465, 2005.
4. Iwasaki A and Medzhitov R: Regulation of adaptive immunity by the innate immune system. Science 327: 291-295, 2010.
5. Hoebe K, Janssen E and Beutler B: The interface between innate and adaptive immunity. Nat Immunol 5: 971-974, 2004.
6. Wijbrandts CA, Vergunst CE, Haringman JJ, Gerlag DM, Smeets TJ and Tak PP: Absence of changes in the number of synovial sublining macrophages after ineffective treatment for rheumatoid arthritis: implications for use of synovial sublining macrophages as a biomarker. Arthritis Rheum 56: 3869-3871, 2007.
7. Firestein GS, Nguyen K, Aupperle KR, Yeo M, Boyle DL and Zvaifler NJ: Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium. Am J Pathol 149: 2143-2151, 1996.
8. Yamanishi Y, Boyle DL, Pinkoski MJ, et al: Regulation of joint destruction and inflammation by p53 in collagen-induced arthritis. Am J Pathol 160: 123-130, 2002.
9. Salvador G, Sanmarti R, Garcia-Peiró A, Rodrguez-Cros J, Muñoz-Gómez J and Cañete J: p53 expression in rheumatoid and psoriatic arthritis synovial tissue and association with joint damage. Ann Rheum Dis 64: 183-187, 2005.
10. McGovern DP, Hysi P, Ahmad T, et al: Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease. Hum Mol Genet 14: 1245-1250, 2005.
11. Porcelli S, Yockey CE, Brenner MB and Balk SP: Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8-alpha/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain. J Exp Med 178: 1-16, 1993.
12. Sen M: Wnt signalling in rheumatoid arthritis. Rheumatology (Oxford) 44: 708-713, 2005.
13. Deon D, Ahmed S, Tai K, et al: Cross-talk between IL-1 and IL-6 signaling pathways in rheumatoid arthritis synovial fibroblasts. J Immunol 167: 5395-5403, 2001.
14. Feldmann M and Maini RN: Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases. Nat Med 9: 1245-1250, 2003.
15. Nakano K, Whitaker JW, Boyle DL, Wang W and Firestein GS: DNA methylome signature in rheumatoid arthritis. Ann Rheum Dis 72: 110-117, 2013.
16. Lee HK, Hsu AK, Sajdak J, Qin J and Pavlidis P: Coexpression analysis of human genes across many microarray data sets. Genome Res 14: 1085-1094, 2004.
17. Stuart JM, Segal E, Koller D and Kim SK: A gene-coexpression network for global discovery of conserved genetic modules. Science 302: 249-255, 2003.
18. Lee H-M, Sugino H, Aoki C, et al: Abnormal networks of immune response-related molecules in bone marrow cells from patients with rheumatoid arthritis as revealed by DNA microarray analysis. Arthritis Res Ther 13: R89, 2011.
19. Irizarry RA, Hobbs B, Collin F, et al: Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264, 2003.
20. Diboun I, Wernisch L, Orengo CA and Koltzenburg M: Microarray analysis after RNA amplification can detect pronounced differences in gene expression using limma. BMC Genomics 7: 252, 2006.
21. Yu H, Liu B-H, Ye ZQ, Li C, Li YX and Li YY: Link-based quantitative methods to identify differentially coexpressed genes and gene pairs. BMC Bioinformatics 12: 315, 2011.
22. Liu BH, Yu H, Tu K, Li C, Li YX and Li YY: DCGL: an R package for identifying differentially coexpressed genes and links from gene expression microarray data. Bioinformatics 26: 2637-2638, 2010.
23. Kanehisa M and Goto S: KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28: 27-30, 2000.
24. Huang da W, Sherman BT, Tan Q, Collins JR, Alvord G, Roayaei J, Stephens R, Baseler MW, Lane HC and Lempicki RA: The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists. Genome Biol 8: R183, 2007.
25. Wingender E, Chen X, Hehl R, et al: TRANSFAC: an integrated system for gene expression regulation. Nucleic Acids Res 28: 316-319, 2000.
26. Smoot ME, Ono K, Ruscheinski J, Wang P-L and Ideker T: Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 27: 431-432, 2011.
27. Zhang ML, Huang ZZ and Zheng Y: Estimates and prediction on incidence, mortality and prevalence of breast cancer in China, 2008. Zhonghua Liu Xing Bing Xue Za Zhi 33: 1049-1051, 2012 (In Chinese).
28. Hu F, Mu R, Zhu J, et al: Hypoxia and hypoxia-inducible factor-1α provoke toll-like receptor signalling-induced inflammation in rheumatoid arthritis. Ann Rheum Dis: May 3, 2013 (Epub ahead of print).
29. Xue F, Zhang C, He Z, Ding L and Xiao H: Analysis of critical molecules and signaling pathways in osteoarthritis and rheumatoid arthritis. Mol Med Rep 7: 603-607, 2013.
30. Plantinga TS, Fransen J, Knevel R, et al: Role of NOD1 polymorphism in susceptibility and clinical progression of rheumatoid arthritis. Rheumatology (Oxford) 52: 806-814, 2013.
31. Alexander WS: Suppressors of cytokine signalling (SOCS) in the immune system. Nat Rev Immunol 2: 410-416, 2002.
32. Kubo M, Hanada T and Yoshimura A: Suppressors of cytokine signaling and immunity. Nat Immunol 4: 1169-1176, 2003.
33. Egan PJ, Lawlor KE, Alexander WS and Wicks IP: Suppressor of cytokine signaling-1 regulates acute inflammatory arthritis and T cell activation. J Clin Invest 111: 915-924, 2003.
34. de Hooge AS, van de Loo FA, Koenders MI, et al: Local activation of STAT-1 and STAT-3 in the inflamed synovium during zymosan-induced arthritis: exacerbation of joint inflammation in STAT-1 gene-knockout mice. Arthritis Rheum 50: 2014-2023, 2004.
35. Isomäki P, Alanärä T, Isohanni P, et al: The expression of SOCS is altered in rheumatoid arthritis. Rheumatology (Oxford) 46: 1538-1546, 2007.
36. Nakajima K, Yamanaka Y, Nakae K, et al: A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells. EMBO J 15: 3651-3658, 1996.
37. Feldmann M, Brennan FM and Maini RN: Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 14: 397-440, 1996.
38. Elliott MJ, Maini R, Feldmann M, et al: Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet 344: 1105-1110, 1994.
39. Elliott MJ, Maini R, Feldmann M, et al: Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis. Lancet 344: 1125-1127, 1994.
40. Mihara M, Moriya Y, Kishimoto T and Ohsugi Y: Interleukin-6 (IL-6) induces the proliferation of synovial fibroblastic cells in the presence of soluble IL-6 receptor. Br J Rheumatol 34: 321-325, 1995.
41. Tamura T, Udagawa N, Takahashi N, et al: Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc Natl Acad Sci USA 90: 11924-11928, 1993.